2023 clinical immunization safety assessment (cisa) base IDIQ

Active Awarded Last action

Contract number
75D30123D18248
Awardee
Awarding agency
Task orders
4 $3,415,438 obligated

Award facts

Opportunity
  • 75D30123R72846 Solicitation number
Combined order value
  • $3,421,498 Current, with exercised options
  • $3,703,726 Potential, with all options
Last date to order 62% complete
IDV ceiling 4% used
$86,008,000.12
Maximum order
$86,008,000.12
Award type
Multiple award
Who can order
Only the awarding agency
NAICS code
611210 Junior Colleges
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

About this IDV

CDC Pittsburgh awarded an indefinite-delivery contract to Emory University for Clinical Immunization Safety Assessment (CISA) services with a ceiling of $86,008,000.12 on September 26, 2023. This is a multiple-award vehicle with no set-aside category, established under Executive Order 14398.

The IDIQ supports clinical immunization safety assessment and vaccine safety monitoring activities. Place of performance includes Atlanta, Georgia and Durham, North Carolina.

The contract runs through September 25, 2028. All delivery orders issued under this IDIQ carry cost-no-fee pricing.

Three delivery orders have been issued to date. The first, awarded September 27, 2023, established a base CISA contributing site in Atlanta, Georgia with a ceiling of $1,000,610 and performance through September 27, 2028. A second delivery order, also awarded September 27, 2023, carried a ceiling of $983,726 and performance through September 27, 2026, for clinical and biomedical research supporting vaccine safety. A third delivery order, issued September 27, 2024, funded the CISA Respiratory Syncytial Virus Infants Study contributing site in Durham, North Carolina, with a ceiling of $781,590.89 and performance through September 26, 2027. Across reported orders, Emory has self-performed all work with no subcontractor engagement.

Task orders

Task order Ordering agency Obligated Awarded
Cisa home laiv study contributing site - EO 14398 75D30126F00004 CDC Pittsburgh $910,875
Cisa RSV infants study (contributing site) 75D30124F00003 CDC Pittsburgh $774,481
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00001 CDC Pittsburgh $763,380
2023 clinical immunization safety assessment (cisa) base IDIQ 75D30123F00002 CDC Pittsburgh $966,702

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO 14398 $0
Original award $0

Subawards

Subcontractor Amount Awarded
Children's Medical Group, P.C CISA RSV INFANTS STUDY (CONTRIBUTING SITE) Simultaneous RSV prevention antibody (nirsevimab) and other childhood vaccines in $78,672

Quick answers

Who was awarded contract 75D30123D18248?

75D30123D18248 was awarded to Emory University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 26, 2023.

How much is contract 75D30123D18248 worth?

Orders under 75D30123D18248 have obligated $3,415,438. Their combined current value, with exercised options, is $3,421,498. Their combined potential value, with all options, is $3,703,726. 75D30123D18248's own ceiling is $86,008,000. A single order can be worth up to $86,008,000.

How many orders have been placed under contract 75D30123D18248?

4 orders have been placed under 75D30123D18248, the latest on September 25, 2026.

Who can order from contract 75D30123D18248?

75D30123D18248 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75D30123D18248 part of a contract vehicle?

Yes. 75D30123D18248 is part of Clinical Immunization Safety Assessment 2023 - 2028 (CISA).

Was contract 75D30123D18248 competed?

The extent of competition for 75D30123D18248 was full and open competition. The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV